Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxyverine ECG and Tolerability Study in Healthy Volunteers
NCT02183649Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of pentoxyverine in cough, sponsored by Boehringer Ingelheim. Primary endpoint: changes from baseline in QTc interval up to 24 hours. Started Nov 2009; status: completed.
02
Drugs
pentoxyverine
03
Conditions
cough
Beyond the preview
Go deeper on NCT02183649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183649.